Large-scale testing (Phase 3)Ended earlyNCT01006252What this trial is testingTasisulam-sodium Versus Paclitaxel as Treatment for Metastatic MelanomaWho this might be right forMelanoma Eli Lilly and Company 336
Testing effectiveness (Phase 2)Study completedNCT03200847What this trial is testingPembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced MelanomaWho this might be right forStage IV MelanomaStage III MelanomaAdvanced Melanoma University of Colorado, Denver 26
Testing effectiveness (Phase 2)Ended earlyNCT01723813What this trial is testingPeptide Vaccinations Plus GM-CT-01 in MelanomaWho this might be right forMetastatic Melanoma Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Early research (Phase 1)Ended earlyNCT00492440What this trial is testingInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Cytheris SA 9
Early research (Phase 1)Study completedNCT01107418What this trial is testingA Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 52
Testing effectiveness (Phase 2)Study completedNCT00334776What this trial is testingVaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) University of Southern California 6
Not applicableLooking for participantsNCT06887348What this trial is testingAssess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3Who this might be right forMelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more Replimune Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00350597What this trial is testingGM-CSF as Adjuvant Therapy of MelanomaWho this might be right forMalignant Melanoma Northern California Melanoma Center 50
Testing effectiveness (Phase 2)Study completedNCT02259231What this trial is testingRTA 408 Capsules in Patients With Melanoma - REVEALWho this might be right forMelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma Biogen 41
Testing effectiveness (Phase 2)Study completedNCT02379195What this trial is testingPeginterferon and TIL Therapy for Metastatic MelanomaWho this might be right forMetastatic Melanoma Inge Marie Svane 12
Early research (Phase 1)Ended earlyNCT01611675What this trial is testingLeflunomide+Vemurafenib in V600 Mutant Met. MelanomaWho this might be right forMelanoma Massachusetts General Hospital 3
Testing effectiveness (Phase 2)Study completedNCT00121225What this trial is testingVorinostat in Treating Patients With Metastatic or Unresectable MelanomaWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT04526899What this trial is testingInvestigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of TreatmentWho this might be right forMelanoma Stage IIIMelanoma Stage IVUnresectable Melanoma BioNTech SE 184
Testing effectiveness (Phase 2)Ended earlyNCT02771626What this trial is testingStudy CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)Who this might be right forClear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC) Calithera Biosciences, Inc 118
Testing effectiveness (Phase 2)Study completedNCT00004135What this trial is testingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) University of Chicago 19
Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Testing effectiveness (Phase 2)Ended earlyNCT00072189What this trial is testingA Phase II Study of UCN-01 in Metastatic MelanomaWho this might be right forRecurrent MelanomaStage IV Melanoma National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Not applicableStudy completedNCT01886235What this trial is testingIntravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by SurgeryWho this might be right forRecurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT02821000What this trial is testingSafety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)Who this might be right forMelanoma Merck Sharp & Dohme LLC 103